Low-molecular-weight heparins in the treatment of venous thromboembolism

Current Controlled Trials in Cardiovascular Medicine

Volumn 1, Issue 2, 2000, Pages 102-106

  Ageno, Walter ^a   Huisman, Menno V ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Low molecular weight heparins; Pulmonary embolism; Treatment; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11A; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN; TINZAPARIN;

BLEEDING; CHEMICAL ANALYSIS; CLINICAL PRACTICE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED DISEASE; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG SAFETY; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORBIDITY; PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; SHORT COURSE THERAPY; THROMBOCYTOPENIA; VEIN THROMBOSIS;

EID: 0034467716     PISSN: 14686708     EISSN: None     Source Type: Journal    
DOI: 10.1186/CVM-1-2-102     Document Type: Review

References (23)

1. A population based survey of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study
2. Antithrombotic therapy for venous thromboembolic disease
3. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy: The emerging theme of delayed recurrence
4. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis
5. Heparin and low molecular weight heparin. Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
6. Heparin induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin
7. Low-molecular-weight heparins: Pharmacological profile and product differentiation
8. Low molecular Weight heparin
9. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis
10. Comparison of subcutaneous low molecular weight heparin with intravenous standard heparin in proximal deep vein thrombosis
11. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: Meta-analysis
12. Treatment of deep venous thrombosis with low molecular weight heparins
13. Low molecular weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis
14. A meta-analysis comparing low molecular weight heparins with unfractionated heparin in the treatment of venous thromboembolism
15. Treatment of venous thrombosis with intravenous unfractionated heparin administered in hospital as compared with subcutaneous low molecular weight heparin administered at home
16. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
17. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low molecular weight heparin
18. Assessment of outpatient treatment of deep vein thrombosis with low molecular weight heparin
19. Ambulant treatment according to a protocol of deep venous thrombosis in a leg: Efficacious and safe in everyday practice
20. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis
21. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism
22. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire
23. Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism